Another class of drugs, partial agonists of the serotonergic 5-HT1A receptor, such as buspirone, gepirone, and ipsapirone, was identified as valuable for improving the clinical management of anxiety [9], but their therapeutic effects are delayed for 1–3 weeks [10]. The gene discussed is HTR1A; the disease is Anxiety.